J. Goldman & Co’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,393
Closed -$1.14M – 319
2019
Q1
$1.14M Buy
+1,393
New +$1.13M 0.06% 193

Other funds holding MTNB

J. Goldman & Co's MTNB Position: Q2 2019 in Review

J. Goldman & Co sold out of Matinas BioPharma (MTNB) in Q2 2019, closing a stake of 1,393 shares — an estimated $1.14M sold.

J. Goldman & Co first reported a position in MTNB in Q1 2019 and held it in 1 quarter. The position peaked at $1.14M in Q1 2019. 45 funds tracked by Wall St. Rank hold MTNB as of Q2 2019.

  • J. Goldman & Co reported no remaining Matinas BioPharma position as of Q2 2019 after selling out during the quarter.
  • J. Goldman & Co sold 1,393 Matinas BioPharma shares in Q2 2019, an estimated $1.14M.
  • J. Goldman & Co first reported a position in Matinas BioPharma in Q1 2019 and held it in 1 quarter.
  • J. Goldman & Co's Matinas BioPharma position peaked at $1.14M in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2019.

Based on J. Goldman & Co's 13F filing for Q2 2019, filed 14 Aug 2019.